ACROBiosystems社 プロダクトリスト：Recombinant Protein
- Biotinylated Mouse M-CSF R / CSF1R / CD115 Protein, His Tag & Avi Tag (Avitag)
- M-CSF R
|Characteristics||This protein carries an Avi tag (Avitag) at the C-terminus, followed by a polyhistidine tag. The protein has a calculated MW of 58.4 kDa. The protein migrates as 78-115 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.|
|Endotoxin Level||Less than 1.0 EU per μg by the LAL method.|
|Purity||>95% as determined by SDS-PAGE.|
|Description||Colony stimulating factor 1 receptor (CSF1R) is also known as macrophage colony-stimulating factor receptor (M-CSFR), CD115 Cluster of Differentiation 115 (CD115), C-FMS, CSFR, FIM2, FMS, and is a member of the typeⅢ subfamily of receptor tyrosine kinases (RTKs). CSF1R is a receptor for a cytokine called colony stimulating factor 1, The protein encoded by the CSFR1 gene is the receptor for colony stimulating factor 1, a cytokine which controls the production, differentiation, and function of macrophages. This receptor mediates most, if not all, of the biological effects of this cytokine. Ligand binding activates CSFR1 through a process of oligomerization and transphosphorylation . Mutations in CSF1R are associated with chronic myelomonocytic leukemia and type M4 acute myeloblastic leukemia. Increased levels of CSF1R1 are found in microglia in Alzheimer's disease and after brain injuries. The increased receptor expression causes microglia to become more active. Both CSF1R, and its ligand colony stimulating factor 1 play an important role in the development of the mammary gland and may be involved in the process of mammary gland carcinogenesis.|
|Reference||(1) Ridge, et al., 1990, Proceedings of the National Academy of Sciences 87 (4): 1377?80.
(2) Mitrasinovic, O. M., 2005, Journal of Neuroscience 25 (17): 4442?51.
(3) Tamimi, R. M., 2008, Cancer Research 68 (1): 18?21.
(4) Pollard, J. W., 1994, Proceedings of the National Academy of Sciences 91 (20): 9312?6.
(5) Sapi, Eva, 2004, Experimental Biology and Medicine 229 (1): 1?11.